On 19 September 2013 a letter was addressed to the Members of the Civil Liberties Committee (LIBE) of the European Parliament on the General Data Protection Regulation and Consent in the field of research. The letter is accessible here

On 18th September 2013, CPME addressed European institutions and the US Ambassador to the European Union regarding the PRISM program. The letter is available here.

On 18 September 2013, the CPME addressed Heads of EU Institutions and the US Ambassador to the EU on the PRISM Program The letter is available here

On 17 September 2013, the CPME Executive Committee adopted the “ CPME Response to the EMA public consultation on the “Publication and access to clinical-trial data” Policy” (CPME 2013/088 FINAL)

 On 11 July 2013, the CPME Executive Committee adopted the ‘CPME Response to the public consultation on the new EU occupational safety and health policy framework’ (CPME 2013/086 FINAL).

On 18 June 2013, CPME along with the European COPD Coalition (ECC), the European Public Health Alliance (EPHA), the European Heart Network (EHN), the Association of European Cancer Leagues (ECL), the European Network for Smoking and Tobacco Prevention (ENSP), the Lithuanian Health Forum, the Lithuanian National Tobacco and Alcohol Control Coalition (NTAKK) and the Smoke […]

On 13 June 2013, the CPME Executive Committee adopted the “CPME Response to the WMA public consultation on the draft revised text of the Declaration of Helsinki”

On 16 May 2013, the CPME Executive Committee adopted the “ CPME Statement on the Report by Jan Philipp Albrecht on the General Data Protection Regulation 2012/0011(COD) and the subsequent LIBE amendments”

On 27 April 2013, the CPME Board co-signed the ’BMA Letter on Minimum Alcohol Pricing’ (CPME 2013/028 FINAL).

On 27 April 2013, the CPME Board adopted the ‘CPME Policy on Childhood Immunisation’ (CPME 2013/035 FINAL).

On 27 April 2013, the CPME Board adopted the ’CPME Statement of Solidarity on the Situation of Healthcare in Cyprus’ (CPME 2013/070 FINAL).

On 27 April 2013 the CPME Board reaffirmed the ‘CPME Statement on the Situation of Healthcare in Greece’ adopted in November 2012 (CPME 2012/176 FINAL).

On 27 April 2013, the CPME Board adopted ‘Antibiotic Resistance: a CPME position paper’ (CPME 2013/020 FINAL).

On 27 April the CPME Board adopted the ‘CPME Statement on the Management of Chronic Conditions’ (CPME 2013/041 FINAL).

On 27 April the CPME Board adopted ‘Healthy ageing: prevention of frailty and functional decline. Joint Statement of the Standing Committee of European Doctors and the European Medical Students’ Association’ (CPME 2013/048 FINAL).  

On 27 April 2013, the CPME Board adopted the “CPME Statement on the Communication from the Commision to the European Parliament, the Council, the European Economic and Social Committee, and the Committee of the Regions on the eHealth Action Plan 2012-2020 : innovative healthcare for the 21st century (COM(2012) 736 final)”  

On 11 April 2013, CPME issued the “CPME Statement on the European Commission proposal for a regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (COM/2012/369)” (CPME 2013/019 FINAL)

 On 18 March 2013, the CPME Executive Committee adopted the CPME position on the Proposal for a Directive of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products” (CPME 2013/015 FINAL)

On 25 February 2013, the CPME Executive Committee adopted the “ CPME Comments on the Consultation on options for revision of the EU Thematic Strategy on Air Pollution and related policies” (CPME 2013/012 FINAL).

On 21 February 2013, the CPME Executive Committee adopted the “CPME response to the public consultation of the European Commission on the implementation of the European Reference Networks“.

The European Commission opened on 17 October 2012 a public consultation on a ‘common logo’ for legally-operating online pharmacies and retailers offering medicinal products for human use for sale at a distance to the public. The Concept paper is available here. The CPME response is available here.

On 15 December 2012, the CPME Executive Committee adopted the “CPME Statement on the revision of the Directive on the transparency of the pricing and reimbursement procedures of medicinal products for human use” (CPME 2012/140 FINAL)

On 4 December 2012, Presidents of European Medical Organisations sent an open letter to EU institutions concerning standards of medical practice (CPME 2012/189).

On 4 December 2012, Presidents of European Medical Organisations sent a joint letter to Commissioner Tonio Borg encouraging the early introduction and implementation of a new Tobacco Products Directive.  (CPME 2012/190).

On 24 November 2012, the CPME Board adopted the “CPME Statement on Non-prescription medicines” (CPME 2012/145 FINAL)